JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on February 23, 2006; DOI: 10.1124/jpet.105.096891


0022-3565/06/3172-546-552$20.00
JPET 317:546-552, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.096891v1
317/2/546    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martirosyan, A.
Right arrow Articles by Strobl, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martirosyan, A.
Right arrow Articles by Strobl, J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

CHEMOTHERAPY, ANTIBIOTICS, AND GENE THERAPY

Actions of a Histone Deacetylase Inhibitor NSC3852 (5-Nitroso-8-quinolinol) Link Reactive Oxygen Species to Cell Differentiation and Apoptosis in MCF-7 Human Mammary Tumor Cells

Anna Martirosyan, Stephen Leonard, Xianglin Shi, Brian Griffith, Peter Gannett, and Jeannine Strobl

Department of Biochemistry & Molecular Pharmacology (A.M., B.G., J.S.), Basic Pharmaceutical Sciences (P.G.), West Virginia University, Morgantown, West Virginia; Pathology & Physiology Research Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, West Virginia (S.L., X.S.); and Biomedical Sciences, Edward Via Virginia College of Osteopathic Medicine and Biomedical Sciences & Pathobiology, Virginia Polytechnic Institute & State University, Blacksburg, Virginia (J.S.)

NSC3852 (5-nitroso-8-quinolinol) has cell differentiation and antiproliferative activity in human breast cancer cells in tissue culture and antitumor activity in mice bearing P388 and L1210 leukemic cells. We investigated the mechanism of NSC3852 action in MCF-7 human breast cancer cells using electron spin resonance (ESR). Reactive oxygen species (ROS) were detected in MCF-7 cell suspensions incubated with NSC3852 using the spin trap 5,5-dimethyl-1-pyrroline-N-oxide (DMPO). Formation of the DMPO-OH adduct was quenched by the addition of superoxide dismutase but not by catalase, and we concluded that superoxide was generated in the NSC3852-treated cells. The flavoprotein inhibitor diphenylene iodonium suppressed ROS production, providing evidence for the involvement of a flavin-dependent enzyme system in the ROS response to NSC3852. A biologically significant oxidative response to NSC3852 occurred in MCF-7 cells. An early marker of oxidative stress was a decrease in the [glutathione]/[glutathione disulfide] ratio 1 h after NSC3852 addition. Oxidative DNA damage, marked by the presence of 8-oxoguanine, and DNA-strand breakage occurred in cells exposed to NSC3852 for 24 h. Apoptosis peaked 48 h after exposure to NSC3852. Pretreatment with the glutathione precursor N-acetyl-L-cysteine (NAC) prevented DNA-strand breakage and apoptosis. Pretreatment with NAC also reversed NSC3852 decreases in E2F1, Myc, and phosphorylated retinoblastoma protein, indicative of redox-sensitive pathway(s) in MCF-7 cells during G1 phase of the cell cycle. We conclude that ROS formation is involved in the apoptotic and cell differentiation responses to NSC3852 in MCF-7 cells.


Received for publication October 16, 2005
Accepted February 22, 2006.

Address correspondence to: Dr. Jeannine S. Strobl, Edward Via Virginia College of Osteopathic Medicine, 2265 Kraft Drive, Blacksburg, VA 24060. E-mail jstrobl{at}vcom.vt.edu




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
S. Song, S. W. Kang, and C. Choi
Trichostatin A enhances proliferation and migration of vascular smooth muscle cells by downregulating thioredoxin 1
Cardiovasc Res, August 13, 2009; (2009) cvp263v2.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. L. Piekarz and S. E. Bates
Epigenetic Modifiers: Basic Understanding and Clinical Development
Clin. Cancer Res., June 15, 2009; 15(12): 3918 - 3926.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.